American Portfolios Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.33M Sell
8,744
-2,513
-22% -$534K 0.1% 208
2022
Q2
$2.3M Sell
11,257
-44
-0.4% -$8.99K 0.09% 220
2022
Q1
$2.38M Buy
11,301
+157
+1% +$34.1K 0.08% 254
2021
Q4
$2.67M Buy
11,144
+25
+0.2% +$6.43K 0.09% 225
2021
Q3
$3.15M Buy
11,119
+769
+7% +$252K 0.12% 173
2021
Q2
$3.58M Buy
10,350
+3
+0% +$909 0.14% 140
2021
Q1
$2.89M Buy
10,347
+20
+0.2% +$5.39K 0.13% 155
2020
Q4
$2.53M Sell
10,327
-5
-0% -$1.29K 0.13% 154
2020
Q3
$2.93M Sell
10,332
-52
-0.5% -$14.5K 0.17% 120
2020
Q2
$2.78M Sell
10,384
-751
-7% -$226K 0.18% 119
2020
Q1
$3.52M Sell
11,135
-331
-3% -$100K 0.29% 72
2019
Q4
$3.4M Sell
11,466
-473
-4% -$131K 0.24% 94
2019
Q3
$2.78M Buy
11,939
+346
+3% +$80.6K 0.23% 100
2019
Q2
$2.71M Buy
11,593
+9,982
+620% +$2.3M 0.23% 101
2019
Q1
$381K Buy
1,611
+157
+11% +$49.4K 0.04% 436
2018
Q4
$438K Buy
1,454
+30
+2% +$9.57K 0.05% 307
2018
Q3
$503K Buy
1,424
+38
+3% +$13.1K 0.06% 310
2018
Q2
$402K Sell
1,386
-19
-1% -$5.34K 0.05% 325
2018
Q1
$385K Buy
1,405
+181
+15% +$56.2K 0.06% 328
2017
Q4
$390K Buy
+1,224
New +$393K 0.06% 314

Other funds holding BIIB

American Portfolios Advisors's BIIB Position: Q3 2022 in Review

American Portfolios Advisors reduced its Biogen (BIIB) stake by 22% in Q3 2022, selling an estimated $534K and leaving 8,744 shares worth $2.33M. The position accounts for 0.1% of the portfolio, ranked #208.

American Portfolios Advisors first reported a position in BIIB in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.58M in Q2 2021. 986 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • American Portfolios Advisors held 8,744 shares of Biogen worth $2.33M as of Q3 2022.
  • American Portfolios Advisors sold 2,513 Biogen shares in Q3 2022, an estimated $534K.
  • Biogen made up 0.1% of American Portfolios Advisors's portfolio in Q3 2022, its #208 holding.
  • American Portfolios Advisors first reported a position in Biogen in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's Biogen position peaked at $3.58M in Q2 2021.
  • 986 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.